{"name":"Eli Lilly","permalink":"eli-lilly","crunchbase_url":"http://www.crunchbase.com/company/eli-lilly","homepage_url":"http://www.lilly.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":1876,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"317-276-2000","description":"","created_at":"Sun Sep 13 02:10:15 UTC 2009","updated_at":"Thu May 03 03:30:36 UTC 2012","overview":"<p>Eli Lilly and Company engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production. Products Neurosciences products, include: Zyprexa, for the treatment of schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; Cymbalta, for the treatment of major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, and in the United States for the management of fibromyalgia; Strattera, for the treatment of attention-deficit hyperactivity disorder in children, adolescents and adults; Prozac, for the treatment of major depressive disorder, obsessive-compulsive disorder, bulimia nervosa and panic disorder; and Symbyax, for the treatment of bipolar depression. Endocrinology products, include: Humalog, Humalog Mix 75/25, and Humalog Mix 50/50tm, for the treatment of diabetes; Humulin, for the treatment of diabetes; Byetta, for the treatment of type 2 diabetes; Actos, for the treatment of type 2 diabetes; Evista, for the prevention and treatment of osteoporosis in postmenopausal women and for the reduction of the risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast cancer; Forteo, for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture; and Humatrope, for the treatment of human growth hormone deficiency and idiopathic short stature.</p>","image":{"available_sizes":[[[102,60],"assets/images/resized/0005/9606/59606v1-max-150x150.png"],[[102,60],"assets/images/resized/0005/9606/59606v1-max-250x250.png"],[[102,60],"assets/images/resized/0005/9606/59606v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"John","last_name":"C. Lechleiter","permalink":"john-c-lechleiter","image":null}},{"is_past":false,"title":"CFO","person":{"first_name":"Derica","last_name":"W. Rice","permalink":"derica-w-rice","image":null}},{"is_past":true,"title":"Software Engineer","person":{"first_name":"Abhishek","last_name":"Tiwari","permalink":"abhishek-tiwari","image":{"available_sizes":[[[126,140],"assets/images/resized/0011/3316/113316v2-max-150x150.jpg"],[[126,140],"assets/images/resized/0011/3316/113316v2-max-250x250.jpg"],[[126,140],"assets/images/resized/0011/3316/113316v2-max-450x450.jpg"]],"attribution":""}}}],"competitions":[],"providerships":[],"total_money_raised":"$0","funding_rounds":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.marketwatch.com/story/lilly-invests-added-20-million-in-chinas-novast-2012-06-12","source_description":"Lilly invests added $20 million in China's Novast","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":12,"company":{"name":"Novast Laboratories","permalink":"novast-laboratories","image":null}}}],"acquisition":null,"acquisitions":[{"price_amount":7133620000,"price_currency_code":"USD","term_code":null,"source_url":"http://www.internationallawoffice.com/deals/Detail.aspx?g=d5088ab1-4d01-4dc2-aa34-2fb22e5923f0","source_description":"Cap Funding Report","acquired_year":2008,"acquired_month":11,"acquired_day":24,"company":{"name":"Imclone Systems","permalink":"imclone-systems","image":{"available_sizes":[[[146,150],"assets/images/resized/0014/4460/144460v1-max-150x150.jpg"],[[150,154],"assets/images/resized/0014/4460/144460v1-max-250x250.jpg"],[[150,154],"assets/images/resized/0014/4460/144460v1-max-450x450.jpg"]],"attribution":null}}},{"price_amount":66200000,"price_currency_code":"USD","term_code":null,"source_url":"http://www.sgxpharma.com/","source_description":"Lilly Announces Completion of SGX Acquisition","acquired_year":2008,"acquired_month":7,"acquired_day":8,"company":{"name":"SGX Pharmaceuticals","permalink":"sgx-pharmaceuticals","image":null}},{"price_amount":null,"price_currency_code":"USD","term_code":null,"source_url":"http://www.fiercebiotech.com/story/lilly-buys-alnara-undisclosed-sum/2010-07-02?utm_medium=rss&utm_source=rss","source_description":"Lilly buys Alnara for undisclosed sum","acquired_year":2010,"acquired_month":7,"acquired_day":2,"company":{"name":"Alnara Pharmaceuticals","permalink":"alnara-pharmaceuticals","image":{"available_sizes":[[[150,35],"assets/images/resized/0005/0698/50698v1-max-150x150.png"],[[250,58],"assets/images/resized/0005/0698/50698v1-max-250x250.png"],[[260,61],"assets/images/resized/0005/0698/50698v1-max-450x450.png"]],"attribution":null}}},{"price_amount":800000000,"price_currency_code":"USD","term_code":"cash_and_stock","source_url":"http://newsroom.lilly.com/releasedetail.cfm?ReleaseID=527815","source_description":"Lilly to Acquire Avid Radiopharmaceuticals","acquired_year":2010,"acquired_month":11,"acquired_day":8,"company":{"name":"Avid Radiopharmaceuticals","permalink":"avid-radiopharmaceuticals","image":{"available_sizes":[[[150,50],"assets/images/resized/0004/8595/48595v2-max-150x150.png"],[[213,72],"assets/images/resized/0004/8595/48595v2-max-250x250.png"],[[213,72],"assets/images/resized/0004/8595/48595v2-max-450x450.png"]],"attribution":null}}}],"offices":[{"description":"","address1":"Lilly Corporate Center","address2":"","zip_code":"46285","city":"Indianapolis","state_code":"IN","country_code":"USA","latitude":39.7683,"longitude":-86.1582}],"milestones":[{"description":"Eli Lilly backs $250M biotech fund for Asia-Pacific","stoned_year":2010,"stoned_month":5,"stoned_day":20,"source_url":"http://www.fiercebiotech.com/story/eli-lilly-backs-250m-biotech-fund-asia-pacific/2010-05-20?utm_medium=rss&utm_source=rss","source_text":"","source_description":"Eli Lilly backs $250M biotech fund for Asia-Pacific ","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Eli Lilly","permalink":"eli-lilly"}},{"description":"Lilly invests £5.4M in R&D hub in U.K.","stoned_year":2012,"stoned_month":5,"stoned_day":2,"source_url":"http://www.fiercebiotech.com/story/lilly-invests-54-million-rd-hub-uk/2012-05-02","source_text":"","source_description":"Lilly invests £5.4M in R&D hub in U.K.","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Eli Lilly","permalink":"eli-lilly"}}],"ipo":{"valuation_amount":null,"valuation_currency_code":"USD","pub_year":null,"pub_month":null,"pub_day":null,"stock_symbol":"NYSE:LLY"},"video_embeds":[],"screenshots":[],"external_links":[]}